Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Clinical Colorectal Cancer
|
December 17, 2016
Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases
Filippo Pietrantonio, Maria Di Bartolomeo, Christian Cotsoglou, et al.
Clinical Genitourinary Cancer
|
May 3, 2014
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma
Patrizia Giannatempo, Alessandra Alessi, Rosalba Miceli, et al.
Urologic Oncology
|
October 19, 2020
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab
Laura Marandino, Antonella Capozza, Marco Bandini, et al.
European Urology Focus
|
November 11, 2020
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy
Laura Marandino, Antonella Capozza, Marco Bandini, et al.
Oncology
|
September 8, 2017
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions
Rosa Berenato, Federica Morano, Filippo Pietrantonio, et al.
Cancers
|
June 22, 2023
Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer
Wyanne A Noortman, Nicolas Aide, Dennis Vriens, et al.
Clinical Colorectal Cancer
|
December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases
Filippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.
Cancer Treatment Reviews
|
October 27, 2018
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)
Martina Imbimbo, Margaret Ottaviano, Milena Vitali, et al.
Cancers
|
February 11, 2023
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors
Laura Evangelista, Andrea Bianchi, Alessio Annovazzi, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 25, 2023
Can Baseline [<sup>18</sup>F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study
Andrea Bianchi, Maria Luisa De Rimini, Rosa Sciuto, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Clinical Colorectal Cancer
|
December 17, 2016
Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases
Filippo Pietrantonio, Maria Di Bartolomeo, Christian Cotsoglou, et al.
Clinical Genitourinary Cancer
|
May 3, 2014
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma
Patrizia Giannatempo, Alessandra Alessi, Rosalba Miceli, et al.
Urologic Oncology
|
October 19, 2020
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab
Laura Marandino, Antonella Capozza, Marco Bandini, et al.
European Urology Focus
|
November 11, 2020
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy
Laura Marandino, Antonella Capozza, Marco Bandini, et al.
Oncology
|
September 8, 2017
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions
Rosa Berenato, Federica Morano, Filippo Pietrantonio, et al.
Cancers
|
June 22, 2023
Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer
Wyanne A Noortman, Nicolas Aide, Dennis Vriens, et al.
Clinical Colorectal Cancer
|
December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases
Filippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.
Cancer Treatment Reviews
|
October 27, 2018
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)
Martina Imbimbo, Margaret Ottaviano, Milena Vitali, et al.
Cancers
|
February 11, 2023
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors
Laura Evangelista, Andrea Bianchi, Alessio Annovazzi, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 25, 2023
Can Baseline [<sup>18</sup>F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study
Andrea Bianchi, Maria Luisa De Rimini, Rosa Sciuto, et al.
Page
of 3